| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,312 |
18,140 |
$7.95M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,818 |
29,841 |
$7.51M |
| 71045 |
Radiologic examination, chest; single view |
13,194 |
12,746 |
$381K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
957 |
931 |
$248K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,081 |
1,056 |
$241K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,764 |
6,463 |
$219K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,088 |
905 |
$214K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,755 |
4,461 |
$203K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,561 |
11,714 |
$186K |
| 59025 |
Fetal non-stress test |
4,180 |
3,377 |
$168K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
922 |
818 |
$127K |
| 85027 |
|
21,665 |
20,047 |
$121K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,892 |
7,383 |
$108K |
| 81001 |
|
16,587 |
15,844 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,418 |
4,332 |
$73K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,356 |
5,237 |
$70K |
| 80053 |
Comprehensive metabolic panel |
4,167 |
3,877 |
$70K |
| 76801 |
|
497 |
454 |
$46K |
| 70450 |
Computed tomography, head or brain; without contrast material |
741 |
710 |
$41K |
| 36415 |
Collection of venous blood by venipuncture |
25,501 |
24,122 |
$30K |
| 80076 |
|
4,390 |
4,239 |
$29K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
203 |
183 |
$18K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,842 |
2,611 |
$17K |
| 86403 |
|
1,656 |
1,641 |
$17K |
| 86850 |
|
1,232 |
1,161 |
$16K |
| 83690 |
|
3,825 |
3,668 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
513 |
491 |
$16K |
| 84703 |
|
3,254 |
3,140 |
$16K |
| 93975 |
|
66 |
59 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
132 |
127 |
$14K |
| 84484 |
|
2,913 |
2,574 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
462 |
458 |
$11K |
| 84702 |
|
1,143 |
1,035 |
$11K |
| 87077 |
|
1,206 |
1,185 |
$6K |
| 87430 |
|
1,640 |
1,618 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
576 |
540 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
119 |
117 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
482 |
421 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
294 |
285 |
$4K |
| 86900 |
|
1,443 |
1,363 |
$3K |
| 81025 |
|
347 |
331 |
$3K |
| 84112 |
|
87 |
80 |
$3K |
| 74018 |
|
50 |
50 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
284 |
259 |
$3K |
| 86901 |
|
1,432 |
1,352 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
615 |
554 |
$779.73 |
| 82248 |
|
905 |
852 |
$779.46 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15 |
15 |
$587.26 |
| 83880 |
|
163 |
154 |
$542.36 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
21 |
21 |
$531.27 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
144 |
144 |
$498.34 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
26 |
$348.85 |
| 83735 |
|
211 |
195 |
$275.83 |
| 80320 |
|
43 |
40 |
$264.69 |
| 83605 |
|
40 |
37 |
$263.75 |
| 86141 |
|
42 |
40 |
$197.78 |
| 76818 |
|
14 |
13 |
$180.06 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
312 |
299 |
$148.01 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
27 |
24 |
$146.27 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
319 |
296 |
$145.77 |
| 85610 |
|
83 |
71 |
$52.62 |
| 81003 |
|
50 |
49 |
$43.42 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
48 |
41 |
$38.47 |
| 85730 |
|
55 |
43 |
$30.30 |
| J3490 |
Unclassified drugs |
58 |
53 |
$24.34 |
| 87040 |
|
13 |
12 |
$17.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
15 |
$12.52 |
| 87420 |
|
15 |
13 |
$11.91 |
| J7050 |
Infusion, normal saline solution, 250 cc |
32 |
26 |
$1.30 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
42 |
40 |
$0.81 |
| A9270 |
Non-covered item or service |
714 |
371 |
$0.00 |
| 82043 |
|
13 |
12 |
$0.00 |
| 82570 |
|
13 |
12 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
14 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
23 |
15 |
$0.00 |
| 84550 |
|
13 |
12 |
$0.00 |